ϕ29 Scaffolding and connector structure-function relationship studied by trans-complementation  by Li, Rui et al.
Virology 444 (2013) 355–362Contents lists available at ScienceDirectVirology0042-68
http://d
n Corr
Birming
States.
E-m
1 Thjournal homepage: www.elsevier.com/locate/yviroϕ29 Scaffolding and connector structure-function relationship studied
by trans-complementation
Rui Li 1, James E. Cherwa Jr.1, Peter E. Prevelige Jr.n
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, United Statesa r t i c l e i n f o
Article history:
Received 31 May 2013
Returned to author for revisions
26 June 2013
Accepted 2 July 2013
Available online 27 July 2013
Keywords:
Bacteriophage ϕ29
Scaffold
Procapsid
Virus assembly22/$ - see front matter & 2013 Elsevier Inc. A
x.doi.org/10.1016/j.virol.2013.07.001
esponding author at: Department of Microbiol
ham, 845 19th Street South, BBRB 416, Bir
ail address: prevelig@uab.edu (P.E. Prevelige J
ese authors contributed equally to this worka b s t r a c t
A dodecamer of connector protein forms a conduit at a unique ﬁve-fold vertex in the capsid of many
dsDNA-containing viruses providing the means for DNA entry and egress. The molecular mechanism
guiding the incorporation of one connector per procapsid remains obscure; however, a recent
bacteriophage ϕ29 model suggests that incorporation is coupled to nucleation between the connector
and scaffolding proteins and particular amino acids may promote interactions between the two proteins.
To test this model in vivo, a trans-complementation system using cloned scaffolding genes was
implemented and tested for the ability to complement a ϕ29 amber-scaffolding strain. Wild type
scaffolding gene induction resulted in efﬁcient virion production, whereas synthesis of mutant
scaffolding proteins displayed various phenotypes. Biochemical analyses of the resultant particles
substantiate the previously identiﬁed amino acid residues in connector incorporation. Furthermore,
kinetic studies of virion production using the in vivo trans-complementation system support the
nucleation model.
& 2013 Elsevier Inc. All rights reserved.Introduction
The assembly pathway of many double strand DNA containing
viruses, including the lambdoid phage, herpesviruses and adeno-
viruses proceeds through the formation of a precursor particle
called a prohead or procapsid (Prevelige and Fane, 2012) (Fig. 1A).
The procapsid is composed of icosahedrally disposed coat protein
subunits surrounding an interior volume containing scaffolding
protein rather than nucleic acid. In a subsequent packaging step,
the scaffolding protein is removed either by proteolysis or direct
exit, and the DNA is packaged into the protein shell through the
action of a multi-protein molecular motor. One component of the
motor complex, termed the portal or connector protein, is a ﬁxed
dodecamer located at one of the 5-fold vertices of the icosahedron
(reviewed in Bazinet and King (1985). Other elements of the motor
complex are referred to as terminase components. These proteins
speciﬁcally recognize the viral DNA, deliver it to the connector
complex, and convert chemical energy in the form of ATP into the
mechanical energy required for DNA packaging (reviewed in Black
(1989).ll rights reserved.
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.The procapsid contains a single connector complex, which
replaces the coat protein subunits at one of the twelve 5-fold
vertices (Chang et al., 2006; Tang et al., 2011; Tao et al., 1998).
There is genetic and biochemical evidence for an interaction of the
connector protein with the scaffolding protein in a number of
dsDNA containing viruses including: herpes simplex (Singer et al.,
2005; Yang et al., 2013), P22 (Greene and King, 1996; Weigele
et al., 2005), T4 (Laemmli et al., 1970; Mesyanzhinov et al., 1990),
and lambda (Murialdo, 1979; Murialdo and Becker, 1978a). How-
ever, the mechanism by which a single vertex is differentiated
from the other eleven during assembly has remains obscure.
Models in which it is incorporated as the ﬁrst step of assembly
or as the ﬁnal step of assembly have been proposed (Bazinet et al.,
1990; Cerritelli and Studier, 1996; Moore and Prevelige, 2002;
Murialdo and Becker, 1978b). However, recent experimental
evidence favors the notion that connector incorporation occurs
early during assembly and is perhaps involved in nucleation (Fu
and Prevelige, 2009; Fu et al., 2010).
In the case of the prolate dsDNA containing Bacillus subtilis
bacteriophage ϕ29, the connector complex occupies one of the two
5-fold vertices lying on the long axis of the 43 nm53 nm
procapsid (Tao et al., 1998). The procapsid itself consists of 235
copies of the coat protein and approximately 180 copies of the
internal form determining scaffolding protein (Guo et al., 1987;
Peterson et al., 2001; Tao et al., 1998). Fifty-ﬁve head ﬁber proteins
are bound to the local three-fold positions and thereby decorate
the procapsid (Tao et al., 1998; Xiang and Rossmann, 2011).
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Fig. 1. (A) Schematized assembly pathway for bacteriophage ϕ29. The primary structural proteins: coat gp8 (235 molecules), scaffold gp7 (∼180 molecules), connector gp10
(12 molecules), and head ﬁber gp8.5 (55 trimers) form a prolate procapsid with the dodecamer of connector protein located at one vertex. Five molecules of packaging RNA
(pRNA, not shown) are bound to the connector. ATP-dependent DNA packaging, driven by the terminase protein, results in exit and recycling of the scaffolding protein.
Attachment of the tail yields an infectious virus. (B) The scaffolding (blue)-connector (green) protein docking model (Fu et al., 2010). In the model, a total of six scaffolding
protein dimers interact with a connector dodecamer. They are situated at the interface between every other connector subunit with their N-terminal helix-loop-helix motif
pointed towards the interior of the capsid. (C) The proposed electrostatic interactions of the scaffolding dimer (green) between two connector (gold) subunits.
The scaffolding protein amino acids R69 and E56 are hypothesized to interact with E114 and R110 of the connector, respectively.
R. Li et al. / Virology 444 (2013) 355–362356DNA packaging results in exit of the scaffolding protein, and the
attachment of the tail protein at the portal vertex (reviewed by
(King et al., 1976). Although the crystal structure of the 50 kDa ϕ29
coat protein has not been solved, cryo-electron microscopy recon-
structions demonstrate that the protein assumes the prevalent
HK97 fold (Morais et al., 2005). In contrast, crystal structures ofthe recombinantly-expressed 11 kDa scaffolding and 35 kDa con-
nector proteins are available (Guasch et al., 2002; Morais et al.,
2003; Simpson et al., 2000). The scaffolding protein consists of
three α-helices; the N-terminus displays a helix-loop-helix motif,
while the C-terminus is disordered. Successive deletions of the
scaffolding protein C-terminus revealed its likely participation in
R. Li et al. / Virology 444 (2013) 355–362 357binding to the coat protein during morphogenesis (Fu et al., 2007).
The structure of the connector protein consists of three centrally
located α-helices separating the wide and narrow β-sheet-rich
domains. The dodecamer is arranged as a 75 Å-long “ﬂower pot”-
shaped structure. The 69 Å diameter wide end of the dodecamer
occupies the internal region of the procapsid, whereas the 33 Å
diameter narrow end extends outward to make external contacts
with the other components of the motor complex (Fig. 1B).
In vitro assembly studies using puriﬁed proteins suggest that
a complex of the connector and scaffolding proteins serves to
nucleate assembly (Fu and Prevelige, 2009). Computational dock-
ing studies using the available crystal structures and distance
constraints derived from chemical crosslinking experiments were
previously employed to develop a model for scaffolding-connector
protein interactions (Fu et al., 2010) (Fig. 1C). Models of the
molecular basis of recognition between proteins can be tested
through the introduction and evaluation of site-speciﬁc mutations
at the presumptive interface. For instance, the proposed docking
model was used as a guide to introduce a lysine residue into the
scaffold protein, which resulted in a new lysine-to-lysine crosslink
between the scaffolding and connector proteins in vitro. Based on
the mutagenesis and crosslinking studies a domain model for the
scaffolding protein was proposed in which the C-terminal unstruc-
tured residues bind to and recruit the coat protein subunits, while
the upstream region (residues 65 to 74) dock with the connector
protein to ensure its incorporation (Fu et al., 2007, 2010).
It is desirable to have a facile mechanism to test the role of
scaffolding mutations in vivo. Trans-complementation systems in
which the mutant protein can be expressed from a plasmid and
experimentally tested for its ability to complement a defective
virus provide such an approach. In this manuscript we report the
development of a trans-complementation system for the bacter-
iophage ϕ29 scaffolding protein and its use to test the previously
proposed scaffolding-connector protein docking model.Results
In vitro analysis of scaffolding/coat protein interactions
The docking model predicts that interactions between the
scaffold and connector proteins are mediated at least in part by
electrostatic interactions (Fu et al., 2010). To test this hypothesis,
point mutations predicted to weaken scaffolding-connector pro-
tein interactions, either through the loss of charge/charge attrac-
tions (K66A) or the introduction of charge/charge repulsion (E56K,
R69E), were engineered into a cloned ϕ29 wild type scaffolding
gene (gp7). These mutations are thought to lie in the connector
binding domain and not expected to affect procapsid assembly in
the absence of the connector protein. To ensure that the mutant
proteins retained function, each protein was puriﬁed and tested
for its ability to promote the assembly of procapsid-like particles
in vitro.
Under standard in vitro assembly conditions the coat protein
self-associates into aberrant structures in the absence of wild type
scaffolding protein. However, upon the addition of wild type
scaffolding protein, procapsid-like particles are produced (Fu
et al., 2007). While both aggregation and controlled assembly of
the coat protein result in a time-dependent increase in turbidity,
the kinetics and extent of the increase are typically distinct.
Controlled assembly displays a hyperbolic-shaped progress curve
that levels off after approximately ten minutes, whereas uncon-
trolled coat protein assembly increases linearly throughout the
duration of the experiment (Fig. 2). The assembly kinetics with the
three mutant proteins (E56K, K66A, and R69E) all follow a
trajectory similar to that obtained with the wild type scaffoldingprotein. The rate of assembly and ﬁnal degree of turbidity suggest
the mutant proteins are as efﬁcient as wild type protein in
directing assembly in vitro.
To characterize the products of each reaction, the rapidly
sedimenting species were isolated from the monomeric reactants
by sucrose gradient centrifugation and subsequently visualized by
negative stain electron microscopy. The presence of procapsid-like
particles with morphologies similar to those obtained in the wild
type scaffolding reaction was conﬁrmed for each of the mutant
scaffolding proteins (data not shown). These experiments suggest
that the introduced point mutations have little effect on the ability
of the scaffolding protein to interact with coat protein and
promote particle assembly.
Analysis of scaffolding-connector protein interactions
To determine whether the scaffolding mutants could interact
with the connector in vitro we employed a previously described
assay for scaffolding-connector interactions. This assay is based on
the ability of the scaffolding protein to solubilize the connector
dodecamer at low ionic strength (Fu and Prevelige, 2009). At low
ionic strength, in the absence of wild type scaffolding protein,
the connector protein (gp10) aggregates and is readily removed
from solution by centrifugation (Fig. 3, lane 2). The inclusion of
wild type scaffolding protein (gp7) restores connector solubility
in a concentration dependent fashion. SDS-PAGE analysis of the
supernatant following centrifugation provides a semi-quantitative
measure of solublization (Fig. 3, lanes 3 and 4). When compared to
the wild type scaffolding protein all of the mutant scaffolding
proteins display an abolished ability to solubilize the connector
protein even at the highest concentration (Fig. 3, lanes 5–10)
suggesting that these charge change alterations negatively affect
the binding of the mutant scaffolding proteins to the connector
dodecamer.
Analysis of the effect of scaffolding mutations on virus production
While the in vitro studies support the notion that deﬁned
scaffolding protein mutations can disrupt scaffolding-connector
protein interactions, they are incapable of directly evaluating the
effect of the mutations on virus production. Introducing speciﬁc
point mutations into the 45 kbp ϕ29 genome is technically
demanding and precludes the analysis of potentially lethal muta-
tions. To facilitate these sorts of investigations, an in vivo trans-
complementation system was developed. Brieﬂy, the ϕ29 scaffold-
ing gene was cloned into the shuttle vector pHCM05, which carries
both the E. coli and B. subtilis origins of replication, an IPTG
inducible promoter, and both ampicillin and chloramphenicol
resistance markers (Nguyen et al., 2005). The desired mutations
were introduced by site-directed mutagenesis, veriﬁed by sequen-
cing, and the plasmids were transformed into B. subtilis proto-
plasts. IPTG-driven gene induction resulted in approximately ten-
fold over-expression of wild type or mutant scaffolding gene as
analyzed by Western blotting (data not shown).
To determine if the wild type and mutant scaffolding proteins
were capable of supporting phage replication the trans-comple-
mentation tested by a direct plaque assay. A strain of ϕ29 carrying
an amber mutation at the N-terminus of the scaffolding gene
(amber-gp7) was plated on lawns of B. subtilis spoA12 su cells
harboring plasmids expressing wild type or mutant scaffolding
genes and the number of plaques counted. The strain expressing
the wild type scaffolding gene complemented the amber-gp7
strain and resulted in titers comparable to those obtained when
the amber mutation is suppressed using a su+44 strain of B. subtilis
(Fig. 4). In contrast, the charge reversal mutants E56K and R69E
were defective in their ability to complement the amber-gp7
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Fig. 2. In vitro assembly reactions for scaffolding-promoted assembly. The kinetics
of assembly was monitored by turbidity at 340 nm. The composition of each
reaction is as follows: No protein (closed triangles); WT coat protein (closed
squares); WT scaffold and WT coat proteins (open circles); E56K scaffold and WT
coat proteins (closed circles); K66A scaffold and WT coat proteins (open squares);
R69E scaffold and WT coat proteins (open triangles).
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Fig. 3. In vitro identiﬁcation of connector and scaffolding binding residues. The
ability of wild type or mutant scaffolding proteins to solubilize the connector
protein (16 mM) at low ionic strength was determined by measuring the amount of
connector in the supernatant following centrifugation. Lane 1: Molecular weight
marker; Lane 2: connector protein only; Lanes 3 and 4: connector plus WT
scaffolding protein at 3-fold and 6-fold molar excess, respectively; Lanes 5 and 6:
connector plus E56K scaffolding protein at 3-fold and 6-fold molar excess,
respectively; Lanes 7 and 8: connector plus K66A scaffolding protein at 3-fold.
and 6-fold molar excess, respectively; Lanes 9 and 10: connector plus R69E.
scaffolding protein at 3-fold and 6-fold molar excess, respectively.
R. Li et al. / Virology 444 (2013) 355–362358strain, as titers were only slightly above background. The K66A
mutant protein complemented with a plating efﬁciency compar-
able to that obtained with the wild type scaffolding protein;
however, the plaque sizes were noticeably smaller. These data
indicate that the K66A mutant scaffolding protein can support
progeny production at the level of plaque formation, but there is
likely a functional defect.
Analysis of the kinetics of complementation
To further characterize the trans-complementation system the
kinetics of virus replication was compared to the replication
kinetics of a wild type infection at low multiplicity of infection.
Infections were performed with wild type ϕ29 in non-suppressor
spoA12 su B. subtilis cells, the amber-gp7 strain in suppressor
su+44 cells, and the amber-gp7 strain in the trans-complementation
system using both the wild type and the K66A mutant scaffolding
proteins synthesized in spoA12 su cells (Fig. 5). The wild type ϕ29
infection in su cells and the amber-gp7 infection in su+44 cells
both display a 40 min lag phase; the rate of progeny production
and ﬁnal virion yield are nearly identical. The amber-gp7 infection
in cells expressing the wild type scaffolding protein exhibited an
extended lag phase with a further delay of approximately 20 min
in the onset of exponential phase. However, the ﬁnal yield was
comparable to the control infections. In contrast, the rate of phage
production upon trans-complementation with the K66A scaffold-
ing protein displayed a 40 min delay in the onset of exponential
phase and a greater than ten-fold decrease in ﬁnal yield relative to
the control infections. This result is consistent with the smaller
plaque sizes observed in the complementation analyses.
Mechanistic analysis of the defective scaffolding proteins
Mutations in the scaffolding gene were designed to test the
scaffolding-connector docking model by speciﬁcally disrupting
scaffolding-connector protein interactions without otherwise
interfering with scaffolding protein function in assembly. Thus,
it was hypothesized that expression of the mutant genes would
result in the production of procapsid-like particles that lack the
connector dodecamer and therefore cannot mature into virion.
As expected, each of the mutant scaffolding proteins displayed a
severely diminished ability to properly complement the amber-gp7
strain and produce phage. To determine if procapsids or
procapsid-like particles formed, cells were lysed two-hours after
a amber-gp7 phage infection and scaffolding gene induction.
The lysates were clariﬁed and the proteins, procapsids, and phage
were separated by sucrose gradient centrifugation as described in
Materials and Methods. Following centrifugation, each gradient
was separated into approximately 40 fractions. The protein com-
position of each fraction was analyzed by Western Blot using
antibodies that recognize coat and head ﬁber proteins (Fig. 6, top
panel A–F) or connector protein (Fig. 6, bottom panel A–F).
The amber-gp7 infection in su+44 cells (Fig. 6, top panel A) or in
spoA12 su cells expressing wild type scaffolding protein (Fig. 6,
top panel B) displayed coat and head ﬁber proteins throughout the
entire gradient, with peak intensities present in fractions 5–9 and
15–21. Titering each fraction demonstrated that virions sediment
to fractions 5–9. Electron microscopy of fractions 15–21 identiﬁed
these as the procapsid containing fractions. Western Blots using
the anti-connector antibody (lower panels) displayed peaks of
connector protein in the same fractions suggesting that the
connector was incorporated into both procapsids and virions.
As expected, amber-gp7 infections in spoA12 su cells not
harboring a plasmid to express scaffolding protein do not yield
virions. Fig. 6F (top panel), indicates that the coat protein can be
detected throughout the gradient consistent with mixedpopulations of unassembled protein and aberrant particles. The
bottom panel demonstrates that in the absence of scaffolding
protein the connector is not incorporated and remains toward the
top of the gradient (fractions 23–27).
As can be seen in Fig. 6C–E, the mutant scaffolding proteins
display three different phenotypes. The K66A scaffolding protein,
which weakly complements the amber-gp7 strain shows the
presence of capsid and connector proteins in fractions 5–7 con-
sistent with virion production. However, the majority of the coat,
head ﬁber and connector proteins sediment to the region corre-
sponding to procapsids at the top of the gradient, indicating a
moderate defect in connector incorporation and/or conversion to
infectious virions (Fig. 6C). Surprisingly, the E56K scaffolding
protein appears to form procapsids, which have incorporated the
connector but fail to yield infectious virions (Fig. 6D), suggesting
an alternative phenotypic defect such as a packaging error or the
formation of aberrant particles. Lastly, the R69E scaffolding protein
fails to incorporate the connector and is also defective in produ-
cing procapsids or infectious phage (Fig. 6E).
Morphological characterization of the puriﬁed particles pro-
duced during each infection was performed using electron micro-
scopy (Fig. 7A–C). EM images of the particles obtained from the
amber-gp7 infection in su+44 cells show prolate, tailed particles
R. Li et al. / Virology 444 (2013) 355–362 359with a morphology typical of ϕ29 virion (Fig. 7A). Particles
acquired from the amber-gp7 infection in cells expressing the
E56K mutant scaffolding protein are non-infectious with mixed
morphologies (Fig. 7B) with a population of these particles display
a prolate nature. However, the particles isolated from the amber-
gp7 infection in cells expressing the R69E scaffolding protein are
isometric (Fig. 7C), a characteristic consistent with a failure to
incorporate the dodecameric connector complex (Choi et al., 2006;
Hagen et al., 1976).1× 1010Discussion
The assembly of many dsDNA containing bacteriophage proceeds
through the formation of a precursor particle called a prohead or
procapsid. The B. subtilis bacteriophage ϕ29 procapsid is composed of
235 copies of the coat protein, approximately 180 copies of the
scaffolding protein and a single dodecamer of connector protein
located at a ﬁve-fold vertex (Guo et al., 1987; Peterson et al., 2001;
Tao et al., 1998). Previous in vitro assembly experiments using
puriﬁed ϕ29 coat, scaffold, and connector proteins suggest that the
mechanism guiding the incorporation of a single dodecamer per
procapsid involves the formation of a nucleation complex between
the scaffolding and connector proteins (Fu and Prevelige, 2009;
Fu et al., 2010). Based upon the available crystal structures, distance
constraints derived from chemical crosslinking experiments and
computational docking studies, a domain model for scaffolding-
connector protein interactions was developed. This model proposed
that the C-terminal unstructured residues of the scaffolding protein
bind to and recruit the coat protein subunits, while the upstream
region (residues 65 to 74) dock with the connector dodecameric
protein to ensure its incorporation (Fu et al., 2007, 2010).
The domain model identiﬁes particular amino acid residues
that may form electrostatic interactions between the scaffolding
and connector proteins. To determine whether charge change
amino acid substitutions would affect binding between the two
proteins, mutant scaffolding genes were cloned, expressed and
assayed for the ability to promote particle assembly and bind to
the wild type connector protein in vitro. Results from this analysis
indicate that the introduced mutations do not affect the ability of
the scaffolding protein to bind the coat proteins and promote
procapsid-like particle assembly, suggesting that the puriﬁed
proteins retain a wild type scaffolding protein fold. However,
in vitro solubilization experiments with puriﬁed scaffolding and
connector proteins indicate that the charge change mutants
abolish the interaction between the scaffolding and connector
proteins.Ti
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Fig. 4. In vivo complementation of a null-gp7 ϕ29 strain. Plating assays were
performed to obtain viral titers of a null-gp7 strain ϕ29 with (black box) and
without (white box) IPTG induction of the cloned WT or indicated mutant
scaffolding gene.To determine if the scaffolding protein residues identiﬁed
in the domain docking model participate in connector binding
in vivo, a trans-complementation system was developed. In direct
plating assays the wild type scaffolding effectively complemented
a amber-gp7 ϕ29. A lysine to alanine substitution was functional
though less efﬁcient whereas two charge reversal mutations failed
to complement the amber-gp7 strain at all.
In an effort to further characterize the developed complemen-
tation system, a kinetic analysis was performed using a wild type
ϕ29 strain and the amber-gp7 strain. As controls, a B. subtilis
spoA12 su cell line was infected with the wild type strain, and a
su44+ cell line was infected with the amber-gp7 strain. The kinetics
of virion production was also analyzed in spoA12 su cells
harboring plasmids induced to express the wild type and K66A
scaffolding proteins. Upon infection, complementation with the
wild type scaffolding protein displayed a slight delay in the onset
of the exponential phase but obtained a ﬁnal progeny yield as the
control infection. In contrast, expression of the K66A protein
demonstrated a signiﬁcant forty minute delay before reaching
exponential phase and a ten-fold decrease in virion yield after two
hours. This result is consistent with the previous published in vitro
analysis indicating that the connector forms a nucleation complex
with the scaffolding protein to promote virus assembly (Fu and
Prevelige, 2009).
Biochemical analyses of the particles generated in cells expressing
the wild type and mutant scaffolding proteins to complement the
amber-gp7 strain indicate the possibility of three different assembly
defects. As expected, complementation with the wild type protein
resulted in the formation of infectious virion. The weakly comple-
menting K66A protein resulted in some virion production, but a
majority of the structural proteins sedimented to a region correspond-
ing to procapsids suggesting a primary defect in a conversion to
infectious virion. The E56K scaffolding protein demonstrated connec-
tor incorporation; however assembled particles were distributed
throughout the gradient, indicating a range of aberrant particles and
possibly a connector that is situated in a manner that affects DNA
packaging. Lastly, the R69E scaffolding protein failed to incorporate the
connector, as the connector protein was only present in the late
fractions of the sucrose gradient. In addition, micrographs of particles
generated in cells expressing the R69E protein display an isometric
appearance, an observation also consistent with a failure to incorpo-
rate the connector.Ti
te
r (
ph
ag
e/
m
l)
0 10 20 30 40 50 60 70 80 90 100 110 120
Time (minutes)
1× 1009
1× 1008
1× 1007
1× 1006
Fig. 5. The kinetics of virion production. Each indicated host strain was induced
and infected with the null-gp7 ϕ29 strain. At indicated time points, the infected
cells were lysed with chloroform and titers were determined on su+44 cells.
Control: WT ϕ29 infection in B. subtilis spoA12 su cells (squares); null-gp7 ϕ29
infection in B. subtilis su+44 cells (diamonds); null-gp7 ϕ29 infection. in B. subtilis
spoA12 su- cells expressing the WT scaffolding gene (circles); null-gp7 ϕ29 infection
in B. subtilis spoA12 su cells expressing the K66A scaffolding gene (triangles).
R. Li et al. / Virology 444 (2013) 355–362360Taken together these experiments support the model that con-
nector incorporation in vivo is coupled to scaffolding docking and
provide validation for the speciﬁc docking model previously proposed.
The delay in replication seen with the K66A mutant coupled with its
decreased yield of infectious phage provides circumstantial evidence
that the formation of a stable connector-scaffold complex is coupled to
nucleation of assembly. Finally, the development of a facile shuttle
vector based trans-complementation systemmakes it much simpler to
investigate the role of particular scaffolding protein residues in ϕ29
replication.Materials and methods
Plasmid construction
To express and purify protein, the mutant scaffolding genes
(E56K, R69E and K66A) were constructed from the pET3c-gp7
plasmid by QuickChanges Site-Directed Mutagenesis Kit (Stratagene)
using the primers (5′-CTCATGAAAAGTTAGCCGCTAAAAAAGATGATCT-
GATCGTG-3′), (5′-GATCGTGTCAAATAGTAAGCTTTTCGAACAGATTGG
TTTGACAGACAAACAG-3′) and (5′-GATGATCTGATCGTGTCAAATAGTG
CGCTTTTCAGACAGATTG-3′), respectively. The resulting plasmids,
pET3c-gp7-E56K, pET3c-gp7-R69E and pET3c-gp7-K66A, were trans-
formed into Escherichia coli BL21 (DE3) cells.
For in vivo complementation, the ϕ29 wild type and mutant
scaffolding coding sequences were ampliﬁed by PCR from plasmids
pET3c-gp7, pET3c–gp7-E56K, pET3c–gp7-R69E and pET3c–gp7-K66A
and digested at the primer-encoded BamHI and XbaI sites, then
ligated into the similarly digested shuttle vector pHCMC05 (from3 5 7 9 11 13 15 17 19 21 23 25 27 29
TopBottom
Capsid (gp8)
Head fiber (gp 8.5) 
Connector (gp10)
Fig. 6. Biochemical analysis of particles synthesized in null-gp7 infected cells.
Each sucrose gradient was prepared as described in Materials and Methods and
separated into approximately 40 fractions. Every other fraction was analyzed by
SDS-PAGE and Western blot, utilizing antibodies recognizing the coat and head
ﬁber proteins (top panels), as well as the connector protein (bottom panels). Only
the relevant fractions are depicted in the ﬁgure. Virion, procapsids, particles and
proteins from null-gp7 infections were generated in B. subtilis su+44 or spoA12
su- non-suppressor cells harboring plasmids expressing the indicated scaffolding
(gp7) gene (A) su+44 suppressor strain (no plasmid); (B) B. WT; (C) K66A;
(D) E56K; (E) R69E; (F). spoA12 su- cells (no plasmid).Bacillus Genetic stock center). The ligation products were transformed
into E. coli DH5α cells to obtain the plasmids, pHCMC05-wt-gp7,
pHCMC05-gp7–E56K, pHCMC05-gp7-R69E and pHCMC05-gp7-K66A,
which were transformed into the B. subtilis spoA12 su cells by
protoplast transformation (Chang and Cohen, 1979).
Protein preparation
The ϕ29 wild type and mutant scaffolding proteins were synthe-
sized in E. coli BL21 (DE3) cells harboring plasmids pET3c-gp7-E56K,
pET3c-gp7-R69E and pET3c-gp7-K66A through IPTG induction
(1 mM). Following cell lysis and clariﬁcation, the mutant proteins
were puriﬁed by ammonium sulfate precipitation (S40) and HI-trap Q
HP column using a NaCl gradient. The scaffolding protein eluted at
180 mM NaCl in 50 mM Tris–HCl (pH 8.0) and 1mM EDTA, and then
dialyzed against TMS buffer (50 mM Tris, pH 7.8, 10 mM MgCl2, and
100 mM) for storage.
The ϕ29 connector protein was synthesized in E. coli BL21 (DE3)
cells carrying the pPLc28D plasmid and was puriﬁed by Hi-Trap SP
HP column and HI-trap Q HP column as described (Fu and
Prevelige, 2009; Poliakov et al., 2007).
The ϕ29 coat protein was initially puriﬁed from inclusion
bodies and refolded at 1 mg/ml in 0.7 M arginine at pH 8.0. The
refolded coat protein bound to a HI-trap Q HP column and eluted
at 150 mM NaCl in the buffer of 100 mM Tris (pH 8.0) and 10 mM
MgCl2 as described previously (Fu et al., 2007).
In vitro assembly reactions
The reactions were performed as previously described (Fu et al.,
2007). Brieﬂy, a 21% PEG-3350, 100 mM Tris (pH 8.0) and 10mM
MgCl2 buffer was equilibrated to 13 1C. A mixture of 20 mM coat
protein and 40 mM scaffolding mutant protein was used to obtain a
ﬁnal buffer of 6%PEG, 60 mM NaCl, 100 mM Tris (pH 8.0) and 10mM
MgCl2. Assembly kinetics weremonitored at 340 nm over a 2 h period.
In vitro solubilization assay
The assay was performed as described previously with some
modiﬁcations (Fu and Prevelige, 2009). Puriﬁed connector protein
(16 μM) was mixed with scaffolding protein at 3 and 6-fold molar
excess. The mixture was dialyzed against 89 mM Tris-borate (pH 8.3)
and 2.5 mM EDTA buffer for 30 min at room temperature and
transferred to TMS buffer for 1 h at room temperature. The samples
were subjected to centrifugation at 13,000 rpm for 15 min, and the
supernatant was analyzed by SDS-PAGE.
In vivo ϕ29 scaffold complementation direct plaque assay
B. subtilis spoA12 su cells carrying the plasmids of pHCMC05-
gp7 mutants and B. subtilis su+44 cells were each grown in 416
media at 37 1C. When cells reached a density of 4108 cells/ml,
they were diluted 5 times in fresh 416 medium and grown another
cycle to reach exponential phase (4108 cells/ml). A 0.3 ml
aliquot of cells was added to 2.0 ml of 416 top agar, which was
supplemented with chloramphenicol and 0.1 ml of either wild
type or amber gp7 ϕ29 viral stocks with and without 0.5 mM
isopropyl β-D-1-thiogalactopyranoside (IPTG). The mixture was
plated on 25 ml LB plates and incubated overnight at 37 1C.
In vivo ϕ29 scaffold complementation assay
B. subtilis spoA12 su cells carrying the plasmids of pHCMC05-
gp7 mutants and su+44 cells were each grown as described above.
Once cells reached exponential phase, an aliquot was supplemen-
ted with IPTG to pre-induce expression of the respective
Fig. 7. Negatively stained electron micrographs of particles generated during
amber-gp7 infections upon expression of the respective scaffolding gene (gp7) in
spoA12 su- cells non-suppressor cells. (A) WT; (B) E56K; (C) R69E.
R. Li et al. / Virology 444 (2013) 355–362 361scaffolding gene and infected with the indicated viral strain at a
multiplicity of infection (MOI)¼0.1. At each ten minute time point,
over the course of two hours, 0.1 ml of the infected culture was
removed and plated on lawns of su+44 cells to obtain the titer and
spoA12 su cells to ensure the retention of the amber phenotype.
The plates incubated overnight at 37 1C.Detection of virion, procapsids and assembled particles
from infected cells
B. subtilis spoA12 su cells carrying the plasmids of pHCMC05-
gp7 mutants and su+44 cells were each grown as described above.
Cells at were harvested and subjected to centrifugation at
5000 rpm for 10 min at room temperature, then resuspended in
416 media and concentrated to 2109 cells/ml.
The concentrated cells were infected with the amber gp7 ϕ29
strain at a multiplicity of infection (MOI) of 10 and shaken for
5 min at room temperature. The mixture was diluted 10 times
with 416 media with or without IPTG (0.5 mM), incubated at 37 1C
for 2 h and shaken at 200 rpm. The cells were lysed with egg white
lysozyme (20 mg/ml) and DNase I (5 mg/ml). Cell debris was
clariﬁed by centrifugation (5000 rpm) for 30 min at room tem-
perature. The supernatant was then used to obtain phage titers
and isolated particles.
The supernatant obtained above was sedimented at 40,000 rpm
for 1 h in a Beckman Ti 42.1 rotor; the pellet was resuspended in
0.5 ml TMS buffer and allowed to shake overnight at 4 1C. The
resuspension was loaded onto a CsCl density gradient of 1.3–1.7 g/
cm3 in a buffer of 50 mM Tris (pH 7.6),100 mM MgCl2 and
centrifuged at 38,000 rpm for 2 h in a Beckman SW41 Ti rotor
and fractionated to isolate procapsids, virion and aberrant struc-
tures. The relevant fractions were stained by 2% uranyl acetate and
observed under the transmission electron microscope. The same
resupension was also loaded onto a 5–30% sucrose gradient,
centrifuged with a SW55 rotor at 41,000 rpm for 50 min at 4 1C
and fractionated. The fractions were analyzed by SDS-PAGE, and the
presence or absence of connector protein was determined through
Western Blot with anti-connector antibodies.Acknowledgments
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